Search

Search Constraints

You searched for: Author/Creator Enzinger, Peter

Search Results

1. 261 Association of T-cell–inflamed gene expression profile and PD-L1 status with efficacy of pembrolizumab in patients with esophageal cancer from KEYNOTE-180. (9th November 2020)

3. Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor–Amplified Gastroesophageal Cancer: Retrospective Global Experience. Issue 22 (1st August 2022)

4. Feasibility of Computer‐Based Self‐Administered Cancer‐Specific Geriatric Assessment in Older Patients With Gastrointestinal Malignancy. (3rd January 2013)

5. Florid Foreign Body-type Giant Cell Response to Keratin Is Associated With Improved Overall Survival in Patients Receiving Preoperative Therapy for Esophageal Squamous Cell Carcinoma. (31st December 2021)

6. Florid Foreign Body-type Giant Cell Response to Keratin Is Associated With Improved Overall Survival in Patients Receiving Preoperative Therapy for Esophageal Squamous Cell Carcinoma. (December 2021)

7. KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer. (8th February 2019)

8. Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer. Issue 1 (December 2016)

9. Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer. Issue 10 (October 2021)

10. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study. Issue 10302 (28th August 2021)